Explores the diagnostic potential of miR-34c-5p in acute cerebral infarction, highlighting its prognostic significance.
OBJECTIVE: This study aimed to explore the role of miR-34c-5p in ACI to provide novel insights for ACI clinical management. METHODS: This study enrolled 376 subjects (176 healthy individuals, 200 ACI patients). Serum miR-34c-5p expression was quantified by qRT-PCR, with its diagnostic potential evaluated by receiver operator characteristic (ROC) curve. The association between miR-34c-5p and ACI severity was evaluated by correlation analysis. Dual-luciferase assay validated miR-34c-5p/FOSL1 interaction. An oxygen-glucose deprivation and reperfusion (OGD/R)-induced SH-SY5Y model was employed for evaluating the effect of miR-34c-5p/FOSL1 axis on cerebral ischemia-reperfusion injury (CIRI). RESULTS: MiR-34c-5p downregulation possessed a diagnostic potential in ACI. The miR-34c-5p expression, negatively correlating with the NIHSS scores of ACI subjects, was lower in ACI subjects with moderate/severe severity and unfavorable prognosis. MiR-34c-5p downregulation and higher NIHSS scores were risk factors for ACI poor prognosis. OGD/R reduced cell viability, facilitated inflammation (IL-6, TNF-α), and oxidative stress (decreased SOD activity, increased MDA level) in SH-SY5Y cells. MiR-34c-5p overexpression protected against OGD/R-induced SH-SY5Y injury by improving viability, suppressing inflammation, and oxidative stress via targeting FOSL1. CONCLUSIONS: Downregulation of miR-34c-5p showed a diagnostic potential on ACI and was correlated with ACI severity and prognosis.
No takes yet. Share an insight, caveat, or question.
Jiang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: